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Introduction {#sec1}
============

The Hippo pathway is involved in multiple developmental and regenerative processes, such as tissue renewal of the liver, heart, kidney, intestine, and lung. The Hippo pathway needs to be tightly and dynamically regulated, as otherwise hyperactive yes-associated protein/transcriptional co-activator with PDZ-binding motif (YAP/TAZ) cause disease, most notably cancer \[[@bib1], [@bib2], [@bib3], [@bib4], [@bib5]\]. The pathway comprises an upstream inhibitory serine-threonine kinase cascade that ultimately activates large tumor suppressor kinase (LATS)1/2, which in turn phosphorylates and thereby inhibits the co-transcriptional regulators YAP/TAZ through cytoplasmic sequestration as well as protein degradation \[[@bib6], [@bib7]\]. The pathway is regulated by both soluble ligands and mechanical stimuli, where the cytoskeleton and Rho-guanosine triphosphatases (GTPases) play central roles in mediating these responses \[[@bib7], [@bib8]\]. Importantly, how mechanical signals are sensed at the plasma membrane and transduced via the Hippo pathway is currently not well understood.

Caveolae, meaning little caves, are multifunctional organelles localized in the plasma membrane and have mechanotransductive and protective roles \[[@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15]\]. They are generated by CAVEOLIN1--3 (CAV1--3) and CAVIN1--4 (also known as PTRF, SDPR, PRKCDBP, and MURC) as well as Eps15 homology domain (EHD) and PACSIN2 proteins \[[@bib16], [@bib17]\]. CAV3 and CAVIN4 are muscle-specific caveolar proteins \[[@bib16], [@bib17]\]. CAV1 is essential for caveolae formation in non-muscle cells, whereas CAVIN1 is critical for caveolae formation in all cells \[[@bib18], [@bib19], [@bib20], [@bib21]\].

As both the Hippo pathway and caveolae are regulated by mechanical stimuli, such as shear stress, we sought to investigate whether the Hippo pathway and caveolae are functionally integrated in this process.

Results {#sec2}
=======

YAP/TAZ Drive Caveolar Protein Expression {#sec2.1}
-----------------------------------------

We utilized genome-edited YAP/TAZ double knockout (Y/T KO) and LATS1/2 double knockout (L1/L2 KO) HEK293A cells \[[@bib22]\] and compared these to wild-type (WT) HEK293A cells to examine whether the activity state of YAP/TAZ regulates caveolar protein expression. There was a dramatic reduction in CAVEOLIN and CAVIN protein expression in the Y/T KO cells ([Figures 1](#fig1){ref-type="fig"}A, 1B, 1D--1F, and [S1](#mmc1){ref-type="supplementary-material"}A--S1C). This effect was mirrored in an additional Y/T KO clone ([Figures S2](#mmc1){ref-type="supplementary-material"}A, S2B, and S2E). Moreover, caveolar proteins were markedly increased in L1/L2 KO cells ([Figures 1](#fig1){ref-type="fig"}A and 1C--1F), where YAP/TAZ are hyperactive, as evident from increased YAP/TAZ nuclear localization ([Figures 1](#fig1){ref-type="fig"}A, 1C, [S1](#mmc1){ref-type="supplementary-material"}B, and S1F) and dephosphorylated YAP status ([Figures 1](#fig1){ref-type="fig"}F, 1G, and [S2](#mmc1){ref-type="supplementary-material"}E). Re-introduction of LATS1 into L1/L2 KO cells, but not a kinase dead version, increased YAP phosphorylation and decreased CAVIN1, CAV1, and CYR61 expression ([Figures S2](#mmc1){ref-type="supplementary-material"}G and S2H). The essential proteins for caveolae biogenesis, CAV1 and CAVIN1, therefore mirrored the expression of the well-characterized YAP/TAZ target gene *CYR61* \[[@bib7]\] ([Figures 1](#fig1){ref-type="fig"}F, [S2](#mmc1){ref-type="supplementary-material"}E, and S2G). To determine whether the ability for caveolar protein expression was due to a cell-intrinsic dependence on YAP/TAZ and not merely mediated by paracrine effects, we utilized a mixed cell population immunofluorescence (IF)-based assay. Due to the specificity of the antibodies used ([Figure S1](#mmc1){ref-type="supplementary-material"}A), the assay allowed for direct comparison between Y/T KO cells and WT cells in terms of the CAV1 or CAVIN1 protein levels ([Figures 1](#fig1){ref-type="fig"}H--1L, [S1](#mmc1){ref-type="supplementary-material"}D, S1E, [S2](#mmc1){ref-type="supplementary-material"}C, and S2D). CAV1 and CAVIN1 protein expression, as well as CAV2 ([Figure 1](#fig1){ref-type="fig"}M), was directly dependent on YAP/TAZ cell-intrinsic expression ([Figures 1](#fig1){ref-type="fig"}H--1L). Importantly, upon exogenous plasmid-based re-expression in Y/T KO cells, CAV1 and CAVIN1 could be found co-localizing within plasma membrane domains ([Figure S3](#mmc1){ref-type="supplementary-material"}A). This localization is comparable to that of endogenous CAV1 and CAVIN1 in WT cells ([Figure S3](#mmc1){ref-type="supplementary-material"}B). These data show that YAP/TAZ are required for the expression of the essential caveolar proteins CAVIN1 and CAV1.Figure 1YAP/TAZ Are Necessary for Caveolar Protein Expression(A) Confocal images of wild-type (WT) HEK293A cells labeled for DAPI (blue), YAP/TAZ (red), and CAVEOLIN1 (CAV1) (green).(B and C) YAP/TAZ KO cells (Y/T KO) (B) and LATS1/2 KO (L1/L2 KO) (C) labeled and imaged as cells in (A).Scale bars (A--C) represent 30 μm. (A)--(C) are related to [Figures S1](#mmc1){ref-type="supplementary-material"}A--S1C, S1F, and [S2](#mmc1){ref-type="supplementary-material"}A--S2D.(D) Dot plot of quantified CAV1 levels from images, as shown in (A)--(C). In Y/T KO (red), WT (black), and L1/L2 KO (blue) cells, each dot represents one cell. Means ± SEM.(E) Dot plot of CAVIN1 levels from images as shown in [Figure S1](#mmc1){ref-type="supplementary-material"}B. Means ± SEM.(F) Western blots from Y/T KO, WT, and L1/L2 KO HEK293A cells ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2G). GAPDH and HSP90 serve as loading controls.(G) PhosTag gel-based western blots probed against YAP from cell lysates as in (F) ([Figure S2](#mmc1){ref-type="supplementary-material"}H).(H) Mixed cell culture of Y/T KO and WT HEK293A cells were fixed and labeled for YAP/TAZ (red), CAV1 (green), and DAPI (blue). Arrows: examples of Y/T KO cells. Note, cells with no YAP/TAZ signal have low CAV1 signal. Scale bar represents 30 μm.(I) Close up of cells from red box in (H).(J) Dot plot of CAV1 levels in mixed cell populations of Y/T KO and WT cells analyzed in images as shown in (H). Each dot represents one cell. Means ± SEM.(K) Mixed cell population as in (H) labeled for YAP/TAZ (red), CAVIN1 (green), and DAPI (blue). Arrows: examples of Y/T KO cells. Zoomed-out image is in [Figure S1](#mmc1){ref-type="supplementary-material"}D.(L) Dot plot of CAVIN1 levels in mixed populations of Y/T KO and WT cells carried out on images as shown in (K). Means ± SEM.(M) Cells as in (H), labeled for YAP (green), CAVEOLIN2 (CAV2) (red), and DAPI (blue). Zoomed-out image is in [Figure S1](#mmc1){ref-type="supplementary-material"}E. Arrows: examples of Y/T KO cells.Scale bars in (I), (K), and (M) are 15 μm. Further related is [Figures S7](#mmc1){ref-type="supplementary-material"}N--S7R.

*CAV1* and *CAVIN1* Are Direct YAP/TAZ-TEAD Target Genes {#sec2.2}
--------------------------------------------------------

As YAP/TAZ are transcriptional co-activators, we explored the possibility that the essential role of YAP/TAZ in caveolar protein expression was due to transcriptional regulation. We compared mRNA levels from HEK293A Y/T KO and L1/L2 KO to WT cells ([Figures 2](#fig2){ref-type="fig"}A and 2B). In L1/L2 KO cells, with hyperactive YAP/TAZ, there was an increase in the well-established YAP/TAZ target genes *CYR61* and *CTGF* \[[@bib23], [@bib24]\] as well as of *CAVIN1* ([Figures 2](#fig2){ref-type="fig"}A and 2B), an effect that was paralleled by exogenously expressing hyperactive YAP ([Figure S2](#mmc1){ref-type="supplementary-material"}J). Re-introduction of LATS1, but not a kinase dead version of LATS1, in L1/L2 KO cells lowered the expression of *CYR61*, *CTGF*, *CAV1*, and *CAVIN1* ([Figure S2](#mmc1){ref-type="supplementary-material"}I). In addition, there was a striking absence of *CAV1* and *CAVIN1* mRNA expression as well as of *CYR61* and *CTGF* in Y/T KO cells ([Figures 2](#fig2){ref-type="fig"}A, 2B, and [S2](#mmc1){ref-type="supplementary-material"}F). As YAP/TAZ bind TEAD transcription factors \[[@bib24], [@bib25], [@bib26], [@bib27], [@bib28]\], we treated cells with verteporfin, an inhibitor of the YAP-TEAD interaction \[[@bib29]\]. This resulted in a diminished expression of *CYR61*, *CTGF*, *CAV1*, and *CAVIN1* ([Figure 2](#fig2){ref-type="fig"}C). The binding of YAP to TEAD is partly formed via critical hydrogen bonds to serine94 in YAP \[[@bib24], [@bib25], [@bib26]\]. We stably expressed either vector, WT, or S94A YAP into Y/T KO cells and assessed caveolar protein expression in these cells ([Figure 2](#fig2){ref-type="fig"}D). Only WT YAP was able to induce expression of CYR61, CAV1, and CAVIN1 ([Figure 2](#fig2){ref-type="fig"}D). We again utilized the IF-based mixed culture assay, which revealed that CAV1 and CAVIN1 expression was restored in Y/T KO cells in a cell-intrinsic manner by the re-expression of WT YAP, but not by expression of the TEAD-binding-deficient S94A YAP ([Figures 2](#fig2){ref-type="fig"}E--2J). To establish whether this was indeed due to transcriptional regulation, we performed qPCR analysis of samples prepared from Y/T KO cells expressing WT or S94A YAP. There was a significant upregulation of *CAV1* and *CAVIN1* expression upon re-expression of WT YAP ([Figure 2](#fig2){ref-type="fig"}L). To assess whether TAZ was similarly capable of inducing CAV1 and CAVIN1 expression in Y/T KO cells, we introduced either WT TAZ or a TEAD-binding-deficient TAZ mutant (S51A). Similar to YAP, exogenous TAZ expression induced CAV1 and CAVIN1 expression in the Y/T KO background in a cell-intrinsic and TEAD-binding-dependent manner ([Figures 2](#fig2){ref-type="fig"}K, 2M, [S3](#mmc1){ref-type="supplementary-material"}E, and S3F). This apparent dependence on YAP/TAZ-TEAD interaction prompted us to analyze the role of TEADs in the expression of CAV1 and CAVIN1. We therefore established cells with short hairpin (sh)-mediated knockdown of TEADs. A clear TEAD dependence was evident for the expression of CAV1 and CAVIN1 ([Figures 3](#fig3){ref-type="fig"}A--3F and [S4](#mmc1){ref-type="supplementary-material"}A--S4F).Figure 2*CAV1* and *CAVIN1* Expression Depend on YAP/TAZ-TEAD Interaction(A) qPCR analysis of established YAP/TAZ targets. mRNA from Y/T KO and L1/L2 KO HEK293A cells compared to WT HEK293A cells ([Figures S2](#mmc1){ref-type="supplementary-material"}F and S2I). Means ± SD.(B) qPCR data as in (A), analyzed for the expression of *CAV1* and *CAVIN1* ([Figures S2](#mmc1){ref-type="supplementary-material"}F and S2I). Means ± SD.(C) Verteporfin-treated WT HEK293A cells analyzed by qPCR. Inhibition of the interaction between YAP-TEAD reduces expression of caveolar genes. Means ± SD.(D) Western blots of lysates from Y/T KO cells stably re-expressing either control plasmid, myc-tagged WT, or S94A mutant YAP. l.e., long exposure; s.e., short exposure. Note, re-expression of WT YAP, but not S94A mutant, deficient in TEAD binding, restores expression of caveolar as well as established YAP/TAZ-TEAD target genes, *CYR61* and *LATS2*.(E and F) Mixed population of Y/T KO cells expressing myc-tagged YAP or empty vector ([Figure S3](#mmc1){ref-type="supplementary-material"}C) or mixed population of Y/T KO cells expressing myc-tagged S94A YAP or empty vector and labeled for myc (red), CAV1 (green), and DAPI (blue; F).(G and H) Mixed cell culture of Y/T KO cells expressing either vector control or myc-tagged YAP ([Figure S3](#mmc1){ref-type="supplementary-material"}D) or mixed cell culture of Y/T KO cells expressing either vector control or myc-tagged S94A YAP (H). Myc (red), CAVIN1 (green), and DAPI (blue) are shown.Arrows in (E)--(H) highlight examples of myc-YAP-expressing cells. Scale bars (E)--(H) represent 15 μm. Note, only YAP WT induces expression of CAV1 and CAVIN1.(I) Dot plot of CAV1 levels from images, as shown in (E) and (F). Each dot represents one cell. Means ± SEM.(J) Dot plot of CAVIN1 levels from images, as shown in (G) and (H). Each dot represents one cell. Means ± SEM.(K) Dot plot of CAV1 levels from mixed Y/T KO cell population expressing vector control and TAZ (WT) or TAZ (S51A) labeled for CAV1 and TAZ from images as shown in [Figures S3](#mmc1){ref-type="supplementary-material"}E and S3F.(L and M) qPCR data from myc-tagged WT or S94A YAP compared to vector control expressing Y/T KO cells (L) and WT or S51A TAZ compared to vector control expressing Y/T KO cells levels (M). Means ± SD.Figure 3*CAV1* and *CAVIN1* Are Direct YAP/TAZ-TEAD Target Genes(A) Western blots of lysates from shTEADs and shCon HEK293A cells.(B) Mixed cell population of shTEADs and shCon HEK293A cells labeled for DAPI (blue), CAV1 (red), and TEAD1 (green). Discrete cell populations are shown in [Figure S4](#mmc1){ref-type="supplementary-material"}A (see also [Figure S4](#mmc1){ref-type="supplementary-material"}B).(C) Mixed cell population of shTEADs and shCon HEK293A cells labeled for DAPI (blue), TEAD1 (red), and CAVIN1 (green). Discrete cell populations are shown in [Figure S4](#mmc1){ref-type="supplementary-material"}D.Arrows in (B) and (C): examples of shTEADs cells. Scale bars in (B) and (C) represent 15 μm.(D and E) Dot plot of CAV1 levels from images, as shown in (B) ([Figure S4](#mmc1){ref-type="supplementary-material"}C; D) and dot plot of CAVIN1 levels from images, as shown in (C) ([Figure S4](#mmc1){ref-type="supplementary-material"}E; E). Each dot represents one cell. Means ± SEM.(F) qPCR data from cells as in (A) (related to [Figure S4](#mmc1){ref-type="supplementary-material"}F). Means ± SD.(G) YAP drives *CAVIN1* and *CAV1* promoter activity. Luciferase reporters were generated carrying either a short (−500 to +200 bp), or long (−1,907 to +200 bp) fragment of the *CAV1* promoter region or a fragment (−1,250 to +150 bp) of the *CAVIN1* promoter region (related to [Figure S4](#mmc1){ref-type="supplementary-material"}G). The reporters were introduced into Y/T KO HEK293A cells together with either a YAP or a vector control plasmid. Note that only the long *CAV1* form contains the predicted TEAD recognition motifs. Means ± SD.(H) Real-time PCR analysis of TEAD1 chromatin immunoprecipitation (ChIP) in HEK293A cells. The precipitated DNA was quantitated using primers specific for a promoter region or a control in-gene (Ing) region. Data are means ± SD of triplicates from a representative experiment. Endogenous TEAD1 binds to both *CAV1* and *CAVIN1* promoters.(I and J) YAP ChIP for *CAV1* and *CAVIN1* in shCon HEK293A cells (I) and in shTEADs HEK293A cells (J). Endogenous YAP binds to both *CAV1* and *CAVIN1* promoters in a TEAD-dependent manner.

To determine whether TEAD proteins can localize to *CAVIN1* and *CAV1* promoters, we examined their proximal genomic regions for TEAD recognition motifs ([Figure S4](#mmc1){ref-type="supplementary-material"}G). When a genomic region of *CAV1* (−1,907 to +200 bp) or *CAVIN1* (−1,250 to +150 bp) was inserted into a plasmid upstream of a luciferase open reading frame, expression of YAP increased luciferase activity ([Figure 3](#fig3){ref-type="fig"}G). In contrast, a short *CAV1* genomic region that does not harbor TEAD recognition motifs ([Figure S4](#mmc1){ref-type="supplementary-material"}G) had no effect on the luciferase activity ([Figure 3](#fig3){ref-type="fig"}G).

To examine whether this interaction also takes place *in vivo*, we carried out chromatin immunoprecipitation (ChIP) assays with antibodies against TEAD1. Regions of both *CAVIN1* and *CAV1* proximal promoters, which contain the consensus binding sequence for the YAP/TAZ-TEAD transcriptional complex, were enriched by antibodies targeting TEAD1 ([Figure 3](#fig3){ref-type="fig"}H). To test whether YAP also localized to these regions, we carried out YAP-ChIP assays in both WT and shTEAD cells. In a TEAD-dependent manner, regions in both the *CAVIN1* and *CAV1* promoters were enriched by antibodies targeting YAP ([Figures 3](#fig3){ref-type="fig"}I and 3J). These experiments indicate that the TEAD-YAP complex physically binds to promoters of both essential caveolar genes, *CAVIN1* and *CAV1*.

To explore whether regulation of *CAVIN1* and *CAV1* expression by YAP/TAZ-TEAD is a general phenomenon, we used data from cancer cell line encyclopedia (CCLE) \[[@bib30]\] and conducted pairwise bioinformatic analysis of *CYR61* and *CTGF*, *CAVIN1*, or *CAV1* expression, respectively ([Figure 4](#fig4){ref-type="fig"}A). A strong positive correlation between the well-established YAP/TAZ-TEAD target genes *CTGF*/*CYR61* as well as for *CAV1*/*CYR61* and *CAVIN1*/*CYR61* was apparent. However, there was no correlation between expression of *CYR61* and *FLOTILLIN2* (*FLO2*), another plasma membrane protein \[[@bib31]\], or *HPRT1*, a housekeeping gene ([Figure 4](#fig4){ref-type="fig"}A).Figure 4YAP/TAZ Activity Dictates Caveolar Protein Levels(A) Dot plots of *in silico* bioinformatics analysis of data obtained from cancer cell line encyclopedia (CCLE) in cell lines from 967 subjects. The analysis revealed strong positive correlation between established YAP/TAZ target genes (*CYR61* and *CTGF*) as well as between *CYR61* and *CAV1* or *CAVIN1*. However, there was no correlation for *HPRT1* or for another endolysosomal gene, such as *FLOTILLIN2* (*FLO2*), serving as negative controls ([Figure S5](#mmc1){ref-type="supplementary-material"}A). R values were calculated for each correlation; p \< 0.05; Pearson's correlation coefficient.(B) Western blots from YAP KO U2OS cells with stable shRNA-induced knockdown of *TAZ* or control ([Figure S5](#mmc1){ref-type="supplementary-material"}D).(C) Western blots from TAZ KO U2OS cells with stable knockdown of *YAP* or control ([Figure S5](#mmc1){ref-type="supplementary-material"}D).(D) Western blots from NF2 KO and WT U2OS cells ([Figure S5](#mmc1){ref-type="supplementary-material"}B).(E and F) Confocal image of U2OS WT (E) and NF2 KO cells labeled for YAP/TAZ (green) and DAPI (blue; F). Scale bars represent 20 μm.(G) Dot blots of nuclear-to-cytoplasmic ratio of YAP/TAZ, quantified of images as in (E) and (F). Each dot represents one cell. Means ± SEM.(H) Cell lysates from WT, NF2 KO cells exogenously re-expressing NF2, or NF2 KO control cells were separated in a PhosTag gel and probed for YAP.(I) Lysates, as in (H), separated on a conventional SDS-gel and processed for western blotting.(J) qPCR data from NF2 re-expressors, relative to NF2 KO U2OS control cells. NF2 re-expression reduces expression of *CYR61*, *CAV1*, and *CAVIN1*. Means ± SD.(K) qPCR data from NF2 KO U2OS shTEADs relative to control cells. *TEAD* knockdown reduces expression of *CYR61*, *CAV1*, and *CAVIN1*. Means ± SD ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C).(L) Micrographs from epidermis cells from WT zebrafish embryos. Arrows: examples of caveolae at the plasma membrane.(M) Micrographs from epidermis cells from mutant (*yap*^*−/−*^*:taz*^*−/−*^) zebrafish embryos show no caveolae. Scale bars in (L) and (M) represent 500 nm.(N) Quantification of caveolae from micrographs; each dot represents data from one fish embryo. Means ± SEM.(O) qPCR analysis of zebrafish from 5 embryos of each genotype. Means ± SD.

These data show that YAP/TAZ regulate caveolar genes and induce TEAD-mediated *CAV1* and *CAVIN1* gene expression and that *CAV1* and *CAVIN1* are direct transcriptional targets of this complex.

YAP/TAZ Activity Dictates Caveolar Protein Levels {#sec2.3}
-------------------------------------------------

To investigate whether the YAP/TAZ-TEAD transcriptional complex is essential for the expression of CAV1 and CAVIN1 in other cells, we chose the osteosarcoma cell line U2OS. U2OS cells express high levels of the YAP/TAZ-TEAD target genes *CTGF* and *CYR61* as well as high levels of *CAV1* and *CAVIN1* ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Importantly, although YAP and TAZ are predominantly nuclear in unstimulated U2OS cells, they do have a functional Hippo pathway \[[@bib23]\]. We attempted generating YAP/TAZ KO U2OS cells but were unsuccessful, potentially due to essential YAP/TAZ roles for cell survival in this cancer cell line. We therefore generated genome-edited single YAP and TAZ KO cell lines ([Figure S5](#mmc1){ref-type="supplementary-material"}D) with either knockdown of TAZ (shTAZ) or of YAP (shYAP) ([Figures 4](#fig4){ref-type="fig"}B and 4C). In U2OS cells, as in HEK293A cells, loss of YAP and TAZ resulted in loss of CAV1 and CAVIN1 expression ([Figures 4](#fig4){ref-type="fig"}B, 4C, and [S5](#mmc1){ref-type="supplementary-material"}B).

Neurofibromatosis type 2 (NF2) (also known as merlin) \[[@bib1], [@bib2], [@bib3], [@bib4]\] is the most common mutated Hippo pathway tumor suppressor gene. NF2 acts as an upstream activator of the kinase cascade and therefore as an inhibitor of YAP/TAZ \[[@bib6], [@bib7]\]. We deleted NF2 by CRISPR genome editing in U2OS cells to investigate whether this would increase CAVIN1 and CAV1 expression. As predicted, this was indeed the case ([Figure 4](#fig4){ref-type="fig"}D). Analyzing NF2 KO cells by IF, it was evident that YAP/TAZ localization was increased in the nucleus compared to WT U2OS cells ([Figures 4](#fig4){ref-type="fig"}E--4G). Re-introduction of NF2 into NF2-deficient U2OS cells rescued the phosphorylation state and thus activity of YAP ([Figures 4](#fig4){ref-type="fig"}H and 4I), as well as the mRNA expression and protein levels of CYR61, CAVIN1, and CAV1 ([Figures 4](#fig4){ref-type="fig"}I and 4J). To examine whether this transcriptional regulation was mediated via TEADs, we generated shTEAD, shYAP, and shTAZ NF2 KO U2OS cell lines and compared those to controls ([Figures 4](#fig4){ref-type="fig"}K and [S5](#mmc1){ref-type="supplementary-material"}B). Consistent with previous results, the expression of CAV1 and CAVIN1 was also dependent on TEADs in U2OS WT cells ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C). These results demonstrate that TEADs are required for expression of CAV1 and CAVIN1 in U2OS as in HEK293A cells.

YAP/TAZ double KO is embryonic lethal in both mice \[[@bib32], [@bib33]\] and zebrafish \[[@bib34]\]. To explore whether YAP/TAZ regulation of caveolar proteins is conserved across species and within cells of a living organism, we analyzed 12-somite-stage Y/T KO zebrafish as well as age- and background-matched WT embryos. The samples were processed for electron microscopy (EM), and we quantified the abundance of epidermal caveolae. There was a striking decrease in the abundance of epidermal caveolae in Y/T KO embryos ([Figures 4](#fig4){ref-type="fig"}L--4N). To examine whether this lack of caveolae was due to decreased transcriptional activity of YAP/TAZ target genes, we examined the expression levels of *cavin1* and *cav1* as well as of *cyr61* and *ctgf* in whole fish embryos ([Figure 4](#fig4){ref-type="fig"}O) and observed a substantial downregulation of all four genes in Y/T mutant embryos. Cumulatively, these data suggest that YAP/TAZ-TEAD activity is broadly critical for caveolae expression within vertebrates.

CAVIN1 and CAV1 Regulate YAP/TAZ Activity {#sec2.4}
-----------------------------------------

Although understanding of the external inputs and cell surface components for the Hippo pathway is incomplete, in many contexts, Hippo signaling and its effectors are under feedback control \[[@bib7], [@bib35]\]. With this premise and having established that Hippo signaling directly regulates caveolar gene expression, we investigated whether caveolae modulate the Hippo pathway. We initially generated CAV1 knockdown U2OS cells. These cells showed an upregulation of CTGF and CYR61 ([Figures 5](#fig5){ref-type="fig"}A, 5D, and 5E) protein expression as well as a decrease in the inhibitory pYAP-S127-phosphorylation ([Figure 5](#fig5){ref-type="fig"}A). The lowered protein levels of the cavin proteins (CAVIN1 and CAVIN2), upon knockdown of CAV1, is most likely due to diminished stability of cavin proteins in CAV1-deficient cells ([Figures 5](#fig5){ref-type="fig"}A, [S6](#mmc1){ref-type="supplementary-material"}A, and S6B), consistent with previous reports \[[@bib18]\]. To investigate whether the hyperactivity of YAP/TAZ was due to paracrine effects, we generated mixed cell cultures of shCAV1 and control cells and processed them in parallel for IF. Using antibodies against both CAV1 and YAP/TAZ allowed us to discriminate between these populations of cells ([Figures 5](#fig5){ref-type="fig"}B and [S6](#mmc1){ref-type="supplementary-material"}B). YAP/TAZ nuclear localization was more pronounced in cells deficient of CAV1 ([Figures 5](#fig5){ref-type="fig"}B and 5C). This shows that the shCAV1-mediated YAP/TAZ hyperactivity is due to cell-intrinsic events.Figure 5CAV1 Is a Negative Regulator of YAP/TAZ(A) Western blot analysis of shRNA-induced *CAV1* knockdown or control U2OS cells. Note higher expression of CTGF and CYR61 in *CAV1* knockdown cells.(B) Confocal image of mixed cell population of shCAV1 and shCon cells labeled for YAP/TAZ (green), CAV1 (red), and DAPI (blue; [Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B). Arrows: examples of shCAV1 cells. Scale bar represents 20 μm.(C) Dot plots of quantification of nuclear-to-cytoplasmic ratio of YAP/TAZ from images as in (B). Each dot represents one cell. Means ± SEM.(D) qPCR analysis of shCAV1 cells. Means ± SD.(E) Western blots from U2OS shCon and shCAV1 cell lysates from three independent experiments (nos. 1--3).(F) Quantification from blots in (E) of normalized CYR61 values in U2OS shCAV1 cells compared to shCon cells. Student's t test. Means ± SEM; shCAV1 cells have higher levels of CYR61 than control cells.(G) qPCR analysis of shCAVIN1 U2OS cells compared to control. Means ± SD.(H) Confocal image of mixed cell population of shCAV1 (empty vector) and shCAV1 (CAV1-GFP re-expressor) cells, labeled for YAP/TAZ (red), GFP (green), and DAPI (blue). Re-expression of CAV1 in shCAV1 cells rescues hyperactivation of YAP (related to [Figures S5](#mmc1){ref-type="supplementary-material"}E, [S6](#mmc1){ref-type="supplementary-material"}D, S6E, S6I, and [S7](#mmc1){ref-type="supplementary-material"}D--S7K). Scale bar represents 10 μm.(I) Dot plot of quantification of nuclear-to-cytoplasmic ratio of YAP/TAZ from images as in (E). Each dot represents one cell. Means ± SEM.(J) qPCR analysis of CAV1-GFP-expressing shCAV1 cell line compared to control shCAV1. Means ± SD.Further related to this figure are [Figures S5](#mmc1){ref-type="supplementary-material"}G and S5F.

To investigate whether the upregulation of *CYR61* and *CTGF* in caveolae-deficient cells was caused by increased YAP/TAZ-TEAD transcriptional activity, we prepared qPCR samples of both shCAV1 and shCAVIN1 cells and compared those to control cells ([Figures 5](#fig5){ref-type="fig"}D and 5G). In both shCAV1 and shCAVIN1 cells, an upregulation of YAP/TAZ-TEAD transcriptional activity was evident. Importantly, nuclear-to-cytoplasmic ratio of YAP/TAZ, as well as their transcriptional activity, was restored to WT levels upon re-expression of CAV1 ([Figures 5](#fig5){ref-type="fig"}H--5J and [S5](#mmc1){ref-type="supplementary-material"}E). Together, these data indicate caveolar impact on YAP/TAZ-TEAD activity.

To probe further the concept of caveolae as regulators of YAP/TAZ activity, we examined HEK293A cells with knockdown of *CAVIN1* and *CAV1*. Lowering either CAV1 or CAVIN1 expression caused markedly increased levels of CYR61 expression ([Figure S5](#mmc1){ref-type="supplementary-material"}F). We explored whether this increase was due to transcriptional upregulation and identified that YAP/TAZ target genes indeed were increased in cells with lowered CAV1 expression ([Figure S5](#mmc1){ref-type="supplementary-material"}G), as was the case for U2OS cells ([Figures 5](#fig5){ref-type="fig"}D and 5F). This suggests caveolae as an upstream negative regulator of YAP/TAZ. To examine whether this function is conserved *in vivo*, we utilized *cav1*^*−/−*^*;cav3*^*−/−*^ mutant zebrafish, which lack caveolae \[[@bib12]\]. We developed a labeling procedure that allowed us to examine YAP localization in the epidermis of 48 hr post-fertilization (hpf) embryos ([Figure 6](#fig6){ref-type="fig"}A). There was a clear increase in the YAP nuclear-to-cytoplasmic ratio in *cav1*^*−/−*^*;cav3*^*−/−*^ mutant embryos compared to WT ([Figures 6](#fig6){ref-type="fig"}A and 6B). As YAP/TAZ mutant embryos do not survive until 48 hpf \[[@bib34]\] and we therefore could not fully verify our YAP antibody specificity at this developmental stage, we furthermore utilized a GFP-tagged, TEAD-binding-deficient YAP construct (GFP-YAP-S54A), expressed from an epithelial promoter, and introduced it into *cav1*^*−/−*^*;cav3*^*−/−*^ mutant and WT embryos. This YAP mutant construct was co-expressed with H2A-mCherrry to allow for visualization of the nucleus ([Figure 6](#fig6){ref-type="fig"}C). In the fish embryos, we measured a significant increase in YAP nuclear to cytoplasmic localization in *cav1*^*−/−*^*;cav3*^*−/−*^ compared to WT ([Figures 6](#fig6){ref-type="fig"}C and 6D). Moreover, we examined whether the human TEAD-binding-deficient YAP counterpart (YAP-S94A) was sensitive to well-known YAP stimuli, such as serum stimulation \[[@bib23]\], which was indeed the case ([Figure S5](#mmc1){ref-type="supplementary-material"}H). The co-expression of GFP-YAP-S54A and H2A-mCherry in the embryos therefore allowed us to validate our endogenous embryonic YAP labeling data ([Figures 6](#fig6){ref-type="fig"}A--6D). In addition, embryos from *cav1*^*−/−*^*;cav3*^*−/−*^ mutants were compared to WT and we observed a marked increase in *cyr61* and *ctgf* expression ([Figure 6](#fig6){ref-type="fig"}E). Cumulatively, these data demonstrate YAP/TAZ-TEAD activity is augmented upon caveolae deficiency, and this effect is conserved across species and *in vivo*.Figure 6CAVEOLINs Are Negative Regulators of YAP/TAZ *In Vivo*(A) Images of epithelial cells from WT and *cav1*^*−/−*^*/cav3*^*−/*−^ 48 hpf zebrafish embryos labeled for Hoechst (blue) and YAP (red). Note the increased nuclear YAP localization in *cav1*^*−/−*^*/cav3*^*−/*−^ cells. Scale bars represent 25 μm.(B) Quantification of cellular nuclear-to-cytoplasmic ratio from *cav1*^*−/−*^*/cav3*^*−/*−^ superficial epidermal cells compared to WT. Each dot represents one cell. n \> 100. Means ± SEM.(C) Images from *cav1*^*−/−*^*/cav3*^*−/*−^ and WT zebrafish embryos expressing epidermal EGFP-yap S54A (Tead-binding-deficient zebrafish yap mutant) and H2A-mCherry (nuclear marker). Note the predominantly nuclear YAP localization in the *cav1*^*−/−*^*/cav3*^*−/*−^ epidermal cells compared to WT. Scale bars represent 20 μm.(D) Quantification of nuclear-to-cytoplasmic ratio from *cav1*^*−/−*^*/cav3*^*−/*−^ epidermal cells compared to WT. Each dot represents one cell. n \> 50 from each genotype. Means ± SEM (related to [Figure S5](#mmc1){ref-type="supplementary-material"}H).(E) qPCR analysis from four-day-old *cav1*^*−/−*^*/cav3*^*−/*−^ and WT zebrafish embryos. Means ± SD.

Caveolae Facilitate YAP/TAZ-Mediated Flow Response {#sec2.5}
--------------------------------------------------

As both caveolae \[[@bib9]\] and the Hippo pathway \[[@bib36], [@bib37], [@bib38]\] mediate cellular responses from shear stress, we set out to examine whether caveolae and the Hippo pathway are mechanistically linked in this process. We prepared cell lysates from confluent WT HEK293A cells grown under a range of constant flow rates (0--4.7 × 10^−5^ Dyn/cm^2^) for 18 hr and analyzed YAP/TAZ activity. Specifically, we measured the phosphorylation status of YAP and the expression of CYR61 and compared these cells to Y/T KO cells grown under shear stress. We identified a flow-dependent increase in YAP/TAZ activity, as noted by the dephosphorylation of YAP ([Figure 7](#fig7){ref-type="fig"}A), and increased protein expression of TAZ and CYR61 ([Figure 7](#fig7){ref-type="fig"}B). As 2.1 × 10^−5^ Dyn/cm^2^ is sufficient to activate YAP/TAZ ([Figures 7](#fig7){ref-type="fig"}A and 7B), and well within the range of physiological shear stress \[[@bib39], [@bib40]\], we chose this level for the remaining shear stress experiments. As expected, YAP nuclear localization ([Figures 7](#fig7){ref-type="fig"}C and 7D) and transcription of *CYR61* and *CTGF* were increased in cells that had experienced shear stress ([Figure 7](#fig7){ref-type="fig"}E). The induction of the YAP/TAZ target *CYR61* upon flow is therefore a suitable assay to study the shear-stress-mediated regulation of the Hippo pathway. To examine whether the activation of YAP/TAZ upon flow is mediated via caveolae, we asked whether the flow-mediated induction was different between WT cells and cells with reduced CAV1 expression levels. It was apparent that the fold induction of CYR61 protein expression upon flow was markedly reduced (by 40%) in shCAV1 cells ([Figures 7](#fig7){ref-type="fig"}F, 7G, and [S6](#mmc1){ref-type="supplementary-material"}F). Indeed, in cells with efficient reduction of CAV1, the shear-stress-mediated induction of YAP/TAZ activity was diminished, as determined by the mRNA levels of *CTGF* and *CYR61* ([Figure 7](#fig7){ref-type="fig"}H). To further gain insights into the underlying mechanisms and establish whether this process was mediated via paracrine factors, we generated CAV1 KO cells ([Figures S6](#mmc1){ref-type="supplementary-material"}G, S6H, and [S7](#mmc1){ref-type="supplementary-material"}A--S7C). By a mixed cell culture assay, we determined the localization of YAP in CAV1 KO and WT cells. YAP was more nuclear at steady state in CAV1 KO cells ([Figure 7](#fig7){ref-type="fig"}I), and the flow-induced nuclear translocation of YAP was decreased in CAV1 KO cells compared to WT cells ([Figure 7](#fig7){ref-type="fig"}J). Furthermore, shear stress induced an increase of the YAP/TAZ-TEAD target genes *CTGF* and *CYR61* to a higher extent in WT compared to the CAV1 KO cells ([Figure 7](#fig7){ref-type="fig"}G). Importantly, the re-introduction of CAV1 into CAV1 KO cells rescued this phenotype ([Figures S6](#mmc1){ref-type="supplementary-material"}I and [S7](#mmc1){ref-type="supplementary-material"}D--S7M). CAV1 deficiency in L1/L2 KO did not further increase YAP/TAZ activity levels ([Figures S7](#mmc1){ref-type="supplementary-material"}N--S7R), consistent with saturated YAP/TAZ activity in L1/L2 KO cells ([Figures 1](#fig1){ref-type="fig"}C--1G, [S1](#mmc1){ref-type="supplementary-material"}F, and [S2](#mmc1){ref-type="supplementary-material"}E) \[[@bib6], [@bib7]\]. These data show that YAP/TAZ are activated upon shear stress, that YAP/TAZ are hyperactivated in cells without caveolae, and that shear-stress-mediated activation of YAP/TAZ is facilitated by caveolae.Figure 7Caveolae Facilitate YAP/TAZ-Mediated Flow Response(A) Confluent HEK293A cells were kept in chambers with different flow speeds for 18 hr. YAP/TAZ KO cells were kept at high flow only. Western blot of cell lysates separated on a PhosTag gel and probed for YAP is shown. Note the dephosphorylation (downshift of YAP) and therefore predicted activation of YAP upon flow.(B) Western blots of cell lysates as in (A). Note the increase in CYR61 protein upon flow in WT cells.(C) Confocal images of cells grown without (−) or with flow at 2.1 × 10^−5^ Dyn/cm^2^ (+). Cells labeled for YAP (green) and CAV1 (red) are shown. Scale bar represents 20 μm.(D) Dot plot representing quantification of nuclear-to-cytoplasmic ratio of YAP/TAZ localization from images as in (C). Each dot represents one cell. Means ± SEM.(E) qPCR analysis of HEK293A WT cells kept at either 0 or 2.1 × 10^−5^ Dyn/cm^2^. *CTGF* and *CYR61* mRNA were increased upon flow. Means ± SD.(F) Western blot of cell lysates from either control or shCAV1 cells kept at either 0 (− flow) or at 2.1 × 10^−5^ Dyn/cm^2^ (+ flow). Note induction of CYR61 upon flow in WT cells (related to [Figures S5](#mmc1){ref-type="supplementary-material"}F, S5G, and [S6](#mmc1){ref-type="supplementary-material"}F).(G) Quantification of CYR61 levels from western blots as in (F), normalized to HSP90 levels. n = 3; means ± SD.(H) Relative fold induction of target gene expression in shCAV1 upon flow compared to control cells. Means ± SD.(I) Dot plots of YAP localization from images of cells at steady state. Each dot represents one cell. Means ± SEM.(J) Dot plots of normalized values of flow-induced (2.1 × 10^−5^ Dyn/cm^2^) YAP nuclear localization. Each dot represents one cell. Means ± SEM.(K) Relative fold induction of target gene expression in two separate CAV1 KO clones upon flow was compared to control cells. Means ± SD. Flow-mediated induction of *CTGF* and *CYR61* is CAV1 dependent.Further related to this figure are [Figures S6](#mmc1){ref-type="supplementary-material"}G, S6H, and [S7](#mmc1){ref-type="supplementary-material"}A--S7C.

Discussion {#sec3}
==========

The Hippo pathway is recognized as critical for multiple cellular, developmental, and homeostatic processes \[[@bib1], [@bib2], [@bib3], [@bib4], [@bib5]\]. Due to its central role in many biological contexts, tight regulation of this pathway is required and a variety of feedback mechanisms have evolved \[[@bib7], [@bib35]\]. In this study, we find reciprocal relationships between caveolar function and Hippo signaling. Specifically, we show that YAP/TAZ-TEAD activity directly regulates transcription of components that comprise caveolae. Conversely, loss of caveolae results in Hippo kinase cascade inactivation and thus increased YAP/TAZ-TEAD activity.

Flow sensing plays major roles in multiple cell types, especially during development \[[@bib39], [@bib40]\], in the cardiovascular system \[[@bib40]\], in the kidney \[[@bib39]\], and elsewhere \[[@bib41]\]. The transduction of shear stress into cells has previously been shown to depend, at least in part, on caveolae \[[@bib9], [@bib11]\]. Still, hitherto how caveolae mediate flow sensing and other types of mechanotransduction to the interior of the cell is not well understood \[[@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14]\]. Related, shear stress and other mechanical perturbations can affect Hippo signaling \[[@bib8], [@bib36], [@bib37], [@bib38]\]. Mechanistic insights into how the Hippo pathway is regulated by shear stress and how this cellular response is conferred has been limited \[[@bib36], [@bib37], [@bib38]\]. We observed an upregulation of the matricellular remodeling factors CTGF and CYR61 with increased fluid flow. Notably, we identified that the induction of these YAP/TAZ-TEAD-dependent target genes \[[@bib24]\] by shear stress is partly caveolae dependent. Although a complete understanding of this process remains to be determined, we show that shear stress transduction mediated by caveolae is regulated via LATS-mediated inhibitory phosphorylation of YAP/TAZ. Upon shear stress, the caveolae-facilitated activation of the Hippo kinase cascade is blunted. Consequently, caveolae-depleted cells are less sensitive to shear-stress-mediated YAP/TAZ activation. As caveolae are known to buffer cells from mechanical stress \[[@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib42]\], the feedforward upregulation of caveolar components by YAP/TAZ may represent a protective response.

The connection between caveolar function and Hippo signaling may extend beyond transduction of shear stress. For example, both caveolae and the Hippo pathway also play central roles in metabolic signaling \[[@bib19], [@bib22], [@bib43], [@bib44]\], regeneration \[[@bib45], [@bib46]\], and cancers \[[@bib1], [@bib17]\]. One aspect that merits highlighting is that loss-of-function mutations within the muscle-specific caveolin isoform CAV3 \[[@bib47]\] or CAVIN1 \[[@bib48]\] causes muscular dystrophy. The Hippo pathway is a potent regulator of muscle cells \[[@bib49], [@bib50], [@bib51]\], and intriguingly, there are overlapping gene sets between those upregulated in muscular dystrophy, caused by *CAVIN1* or *CAV3* mutations, and those driven by deregulation of muscular YAP/TAZ-TEAD transcription \[[@bib48], [@bib49], [@bib50], [@bib51]\]. It might therefore be worth pursuing to examine the state of the Hippo pathway within caveolae-deficient muscular dystrophy patients. Targeting the Hippo pathway within these patients may allow for therapeutic intervention \[[@bib1], [@bib2], [@bib3], [@bib4], [@bib5]\]. It is noteworthy that the decrease of caveolar proteins is very dramatic upon YAP/TAZ loss of function, whereas overexpression of YAP/TAZ only modestly increases *CAV1* and *CAVEOLIN1*. It thus appears that YAP/TAZ are essential but might not be sufficient to drive expression of caveolar genes in all scenarios. We anticipate that additional factors regulating nuclear YAP/TAZ-TEAD activity, such as VGLL4 \[[@bib52]\], MRTF-SRF \[[@bib53], [@bib54]\], AP1 \[[@bib55], [@bib56]\], and SWI/SNF \[[@bib57], [@bib58]\], might also play a role in regulating caveolar gene expression. The direct and reciprocal link between caveolae and the Hippo pathway provided here paves the way for further explorations into the biology of these little caves and this potent signaling pathway.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Anti-YAPSanta Cruz BiotechnologyCat\# sc-101199, RRID:[AB_1131430](nif-antibody:AB_1131430){#intref0010}Anti-YAPProteintech GroupCat\# 13584-1-AP, RRID:[AB_2218915](nif-antibody:AB_2218915){#intref0015}Anti-CYR61Santa Cruz BiotechnologyCat\# sc-13100, RRID:[AB_2088733](nif-antibody:AB_2088733){#intref0020}Anti-CTGFSanta Cruz BiotechnologyCat\# sc-14939, RRID:[AB_638805](nif-antibody:AB_638805){#intref0025}Anti-GAPDHSanta Cruz BiotechnologyCat\# sc-25778, RRID:[AB_10167668](nif-antibody:AB_10167668){#intref0030}Anti-CAV1BD BiosciencesRRID:BD610060Anti-CAV2BD BiosciencesRRID:BD610684Anti-HSP90BD BiosciencesCat\# 610418, RRID:[AB_397798](nif-antibody:AB_397798){#intref0035}Anti-panTEADCell Signaling TechnologyCat\# 13295, RRID:[AB_2687902](nif-antibody:AB_2687902){#intref0040}Anti-YAP p127Cell Signaling TechnologyCat\# 4911S, RRID:[AB_2218913](nif-antibody:AB_2218913){#intref0045}Anti-YAP p397Cell Signaling TechnologyCat\# 13619, RRID:[AB_2650554](nif-antibody:AB_2650554){#intref0050})Anti-NF2Cell Signaling TechnologyCat\# 6995S, RRID:[AB_10828709](nif-antibody:AB_10828709){#intref0055}Anti-LATS1Cell Signaling TechnologyCat\# 3477, RRID:[AB_2133513](nif-antibody:AB_2133513){#intref0060}Anti-LATS2Cell Signaling TechnologyCat\# 5888, RRID:[AB_10835233](nif-antibody:AB_10835233){#intref0065}Anti-CAVIN1Cell Signaling TechnologyRRID:Cat\# 69036Anti-YAPAbcamCat\# ab52771, RRID:[AB_2219141](nif-antibody:AB_2219141){#intref0070}Anti-CAVIN1AbcamCat\# ab48824, RRID:[AB_882224](nif-antibody:AB_882224){#intref0075}Anti-GFPAbcamCat\# ab6556, RRID:[AB_305564](nif-antibody:AB_305564){#intref0080}Anti-CAVIN3BethylCat\# A302-419A, RRID:[AB_1907302](nif-antibody:AB_1907302){#intref0085}Anti-CAVIN2Atlas AntibodiesCat\# HPA039325, RRID:[AB_10805473](nif-antibody:AB_10805473){#intref0090}Anti-CAV1Jørgen Vinten, University of CopenhagenSee \[[@bib59]\]Anti-MycCell Signaling TechnologyRRID:Cat\# 2276Anti-mouse IgGsFisher scientificRRID:Cat\#12102270Anti-rabbit IgGsFisher scientificRRID:Cat\#1805935Anti-TEAD1BD BiosciencesCat\# 610923, RRID:[AB_398238](nif-antibody:AB_398238){#intref0095}Anti-Goat Immunoglobulins/HRPDAKORRID:P044901Anti-Rabbit Immunoglobulins/HRPDAKORRID:P044801Anti-Mouse Immunoglobulins/HRPDAKORRID:P044701Goat anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 488Thermo Fisher ScientificCat\# A-11008, RRID:[AB_143165](nif-antibody:AB_143165){#intref0100}Goat anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 594Thermo Fisher ScientificCat\# A-11037, RRID:[AB_2534095](nif-antibody:AB_2534095){#intref0105}Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 594Thermo Fisher ScientificCat\# A-11032, RRID:[AB_2534091](nif-antibody:AB_2534091){#intref0110}Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488Thermo Fisher ScientificCat\# A-11029, RRID:[AB_2534088](nif-antibody:AB_2534088){#intref0115}Goat anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 633Thermo Fisher ScientificCat\# A-21071, RRID:[AB_2535732](nif-antibody:AB_2535732){#intref0120}**Bacterial and Virus Strains**Dh5-alpha *E.coli*Sonja Vermeren, University of EdinburghN/AOne Shot Stbl3 Chemically Competent *E. coli*Life TechnologiesC737303**Chemicals, Peptides, and Recombinant Proteins**VerteporfinSigma-AldrichSML0534-5MGPuromycinVWRCAYM13884G418Scientific Laboratory Supplies LtdG5013Hygromycin BScientific Laboratory Supplies Ltd30-240-CRGeneJet DNA transfection reagentTebu-Bio189SL100488LIPOD293 DNA transfection reagentTebu-Bio189SL100668DMEMGIBCO21969-035FBS, heat inactivatedGIBCO10500-064GlutamineGIBCO25030-024Penicillin/StreptomycinGIBCO15140-122Immuno Western ECL mixmilliporeWBKLS0500AntifadecitifluorAF1-100DMSOSigmaD2650ProLong Diamond Antifade Mountant with DAPIThermo Fisher ScientificP36962HoechstThermo Fisher Scientific3342Formaldehyde Solution, Methanol freeThermo Fisher Scientific28908PolyacrylamideThermo Fisher ScientificBP1408-1**Critical Commercial Assays**RNeasy plus mini kitQIAGEN74136High-capacity cDNA reverse transcriptase kitApplied biosciences4368814Brilliant III Ultra-fast SYBR Green QPCR Master MixAgilent Technologies600883Dual-Glo luciferase assay systemPromegaE2920ChIP-IT Express Enzymatic kitActive Motif Inc.53009DNA Clean & Concentrator-5Zymo ResearchD4003T**Experimental Models: Cell Lines**HEK293AKun-Liang Guan lab, UCSDN/AHEK293TKun-Liang Guan lab, UCSDN/AU2OSJack Dixon, UCSDN/A**Experimental Models: Organisms/Strains***wwtr1* mutant zebrafishLink Lab, Medical College of WisconsinAllele mw49*yap1* mutant zebrafishLink Lab, Medical College of WisconsinAllele mw48*cav1* mutant zebrafishPoss Lab, Duke UniversityAllele pd1104*cav3* mutant zebrafishBagnat Lab, Duke UniversityAllele pd1149**Oligonucleotides**Please refer to [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}N/AN/A**Recombinant DNA**Please refer to [Table S3](#mmc1){ref-type="supplementary-material"}N/AN/A**Software and Algorithms**FijiImageJ<https://fiji.sc/>PrismGraphPad<https://www.graphpad.com/scientific-software/prism/>Photoshop and InDesignAdobe<https://www.adobe.com/uk/creativecloud.html>Excel and WordMicrosoft<https://www.office.com/>BioRenderBioRender<https://app.biorender.io/>**Other**Quasi Vivo QV500 systemKirkstallQV500PF22X0103 peristaltic pumpParkerPARKER PF22X0103Thermanox 13mm coverslipsThermo Fisher Scientific\#174950LightCycler 96 SystemRocheN/AX Ray Film 18x24cm Double SidedScientific Laboratory Supplies LtdMOL7016ThermanoxTM 13 mm coverslipsThermo Fisher Scientific\#174950COVER GLASS ROUND Ø 13 MM NO.1VWR International Ltd.631-1578Immobilon(R)-P Polyvinylidene difluoride membranes,size 26.5 cm x 375 cmSigma-AldrichP2938-1ROL

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Carsten G. Hansen (<Carsten.g.hansen@ed.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### *In vitro* studies: cell lines {#sec4.3.1}

All cell lines were cultivated at 37°C in a humidified, 5% CO~2~ atmosphere. HEK293A, HEK293T, and U2OS cells were cultivated in high glucose DMEM (GIBCO) supplemented with penicillin, streptomycin, 2 mM glutamine, and 10% fetal bovine serum (FBS) if nothing else stated.

The HEK293A and HEK293T cell line are human epithelial cells originating from embryonic kidney of a female. The wild-types (WT) as well as the HEK293A YAP/TAZ, and LATS1/2 double knockout cell lines \[[@bib22], [@bib35]\] were kindly provided by Professor Kun-Liang Guan lab, University of California, San Diego (UCSD). HEK293A cell lines were used to perform experiments while HEK293T cells where used for virus generation. The U2OS cell line originates from human epithelial from the bone of a female suffering from osteosarcoma. The U2OS wild-type was kindly provided to us by Professor Jack Dixon (UCSD). Cells were periodically tested for Mycoplasma contamination but were not authenticated.

### *In vivo* studies: zebrafish {#sec4.3.2}

*Danio rerio* (ZDR strain) were raised and housed in a multi-rack Pentaire aquatics system using water purified by high capacity reverse osmosis coupled with mechanical and biological filtration. The room maintained at 28.5°C and under a 14 hr light / 10 hr dark cycle. Zebrafish were not immunized, but the colony was routinely screened for the following pathogens. All specimens were negative the pathogens assayed: Edwardsiella ictaluri, Flavobacterium columnare, Ichthyophthirius multifiliis, Infectious spleen & kidney necrosis virus (ISKNV), Mycobacterium spp., Mycobacterium abscessus, Mycobacterium chelonae, Mycobacterium fortuitum, Mycobacterium haemophilum, Mycobacterium marinum, Mycobacterium peregrinum, Myxidium streisingeri, Piscinoodinium pillulare, Pleistophora hyphessobryconis, Pseudocapillaria tomentosa, Pseudoloma neurophilia The embryos were harvested at early developmental stages (at the latest 48 hpf) and were not sex matched. Subjects were naive and not previously involved in other procedures prior to the experiments reported here.

The following lines were used to generate *yap;taz* (*wwtr1*) double homozygous mutants.*yap1*^mw48^ (c. 158-161del). This allele has a 4 bp deletion within exon1 \[[@bib34]\].*wwtr1*^mw49^ (c. 156-160del). This allele has a 5 bp deletion within exon1 \[[@bib34]\].

In addition, *cav1;cav3* double homozygous mutants have been described elsewhere \[[@bib12]\]. All experiments involving zebrafish were performed in compliance with the Institutional Animal Care and Use Committee of the Medical College of Wisconsin, protocol number AUA1378.

Method Details {#sec4.4}
--------------

### Generation of knockdown (KD), knockout (KO), and re-expression cell lines {#sec4.4.1}

KD cell lines were generated by retrovirus mediated shRNA knockdown. The virus was generated by co-transfecting pMD2G and pSPAX2 (from the Kun-Liang Guan lab, UCSD) with pKLO.1-vectors coding for shRNAs mediated targeting of YAP (TRCN0000300325), TAZ (TRCN0000370007), and TEADs 1/3/4 as previously described \[[@bib22], [@bib24]\], or CAV1 TRCN0000008002 (shCAV1 \#1), TRCN0000007999 (shCAV1 \#2), or CAVIN1 (TRCN0000430242). shRNA constructs are listed in are listed in [Table S3](#mmc1){ref-type="supplementary-material"}. The virus was harvested, filtered and added to polybrene treated cells of interest. Following 6-8 hr incubation the cell medium was changed. Stable cell lines were generated following puromycin selection. To generate U2OS CAV1 re-expressing cell lines, shCAV1 cells were transfected with CAV1-GFP plasmid (\#14433, Addgene) and stable exogenous CAV1-expressing cells were established by G418-selection (SLS). Plasmids encoding either WT or mutant YAP (S94A or 5SA) as well as WT or mutant TAZ (S51A) are listed in [Table S3](#mmc1){ref-type="supplementary-material"} \[[@bib24], [@bib27]\]. HEK293A CAV1 re-expressing cell lines were generated by lentiviral transduction of CAV1 KO cells with a pBabe vector carrying the open reading frame of human CAV1. Clonal YAP and TAZ (*WWTR1*) knock-out cell lines were generated by transient transfection of CrispR constructs, followed by two days of puromycin selection and one day recovery in medium without puromycin, followed by single cell sorting into 96-well plates \[[@bib22]\]. To generate CrispR-mediated CAV1 KO cell lines, the following oligo nucleotides were ligated and thereafter inserted into pSpCas9(BB)-2A-Puro (PX459 *V2.0*; Addgene plasmid \#48139): CAV1crispr\#1fw CACCGAGTGTACGACGCGCACACCA, CAV1crispr\#1rev AAACTGGTGTGCGCGTCGTACACTC and CAV1crispr\#2fw CACCGTTTAGGGTCGCGGTTGACC, CAV1crispr\#2rev AAACGGTCAACCGCGACCCTAAAC. Cells were transfected using LipoD293 or GenJet transfection reagent (SignaGen Laboratories). CrispR oligos are listed in [Table S2](#mmc1){ref-type="supplementary-material"}.

### Transformation {#sec4.4.2}

Transformation of competent bacteria was carried out by heat shock, where after bacteria were seeded onto selective Petri dishes. The following day single clones were picked and propagated for plasmid harvest.

### Western blotting {#sec4.4.3}

Cell lysate preparation in reducing lysis buffer and western blotting was performed as described in Hansen et al., 2015 \[[@bib22]\] using the following antibodies against YAP/TAZ (sc101199), CYR61 (sc13100), CTGF (sc14939), and GAPDH (sc25778) all from Santa Cruz as well as CAV1 (BD610060), CAV2 (BD610684), and HSP90 (BD610418) from BD Biosciences, pan TEAD (3295), pYAP 127 (4911), pYAP 397 (13619), NF2 (Merlin, 6995), LATS1 (3477), LATS2 (5888), and CAVIN1 (PTRF, 69036) from Cell Signaling Technology, and YAP (ab52771), CAVIN1 (PTRF, ab48824) (only used for western blotting in this study), and GFP (ab6556) from Abcam. Antibodies against CAVIN3 (SRBC, A302-419A) were from Bethyl laboratories and against CAVIN2 (SDPR, HPA039325) were from Sigma. Monoclonal antibodies raised against CAV1 were provided by Jørgen Vinten \[[@bib59]\] (The Panum Institute, University of Copenhagen). Furthermore, HRP-conjugated secondary antibodies were used for western blotting.

Besides conventional SDS gels western blotting was performed with Phos-Tag gels. Therefore, 15 μL Phos-tag reagent (Wako chemicals) and 25 μL of 10mM MnCl~2~ were added to each 7.5% (w/v) polyacrylamide gel while the subsequent steps remained the same. Blots were developed using Immuno Western ECL mix (Millipore) and X-ray films (SLS). A larger area of the scans of western blot films is shown in [Data S1](#mmc2){ref-type="supplementary-material"}.

### RT-qPCR and Primers {#sec4.4.4}

For quantitative reverse transcription PCR (RT-qPCR) mRNA was extracted from cells using the RNeasy plus mini kit (QIAGEN). Complementary DNA (cDNA) was generated using High-Capacity cDNA Reverse Transcriptase kit (Applied Biosystems). qPCR was performed on 1 ng of cDNA using the Brilliant III Ultra-Fast SYBR Green QPCR Master Mix (Agilent Technologies) and the LightCycler 96 System (Roche) according to manufactures instruction. In mammalian cells expression levels of all genes analyzed were normalized to Hypoxanthine-guanine phosphoribosyltransferase (*HPRT1*) levels \[[@bib22]\]. Primer sets against caveolar components were designed using primerbank \[[@bib60]\]. qPCR primers, harvest of samples and preparation of cDNA from zebrafish embryos were carried by established methods \[[@bib34], [@bib42]\]. Samples were normalized to Elongation factor 1-alpha (*ef1a*) \[[@bib34]\]. Primers are listed in [Table S1](#mmc1){ref-type="supplementary-material"}.

### Chromatin immunoprecipitation qPCR (ChIP-qPCR) {#sec4.4.5}

ChIP was performed on HEK293A WT cells using the ChIP-IT Express Enzymatic kit (Active Motif Inc.). For immunoprecipitation anti-mouse IgGs (whole molecule, \#12102270, Fisher Scientific), anti-rabbit IgGs (whole molecule, \#11805935, Fisher Scientific), anti-TEF-1 (TEAD1, \#610923, BD Bioscience), and anti-YAP (ab52771, Abcam) antibodies were used. Subsequent DNA clean up (by DNA Clean & Concentrator-5, Zymo Reseach) was followed by DNA quantification by qPCR analysis and output was normalized to the input DNA. Primer sequences are as follows 5′-TGGCATAACCTGTTGGCATA-3′ and 5′-CCCAAACGCTTCGAAATAAG-3′ (forward and reverse) *CAV1* promoter (CAV1), 5′-TTTCAGAATCTCCTGGTCCAC-3′ and 5′-TTGCTCTCTGTTTCCCTCTC-3′ *CAVIN1* promoter (CAVIN1), 5′-CCTCCGTGTCTCAGTGGTTT-3′ and 5′-TCACCTTGCTTGCCTTTCTT-3′ *CAV1* in gene (CAV1 Ing), and 5′-GCAGTTTTGAGGAGGCAAAG-3′ and 5′-AAATGCTTCCTGGCCCTTAT-3′ *CAVIN1* in gene (CAVIN1 Ing) and *CTGF* was used as a control \[[@bib22]\].

### Immunofluorescence (IF) Microscopy {#sec4.4.6}

Cells were seeded onto poly-D-lysine (Sigma) coated coverslips, fixed with 37**°**C 4% formaldehyde (Sigma) (v/v in PBS), permeabilized and incubated in IF buffer (2.5% FBS, 0.3% Triton-x-100 (v/v) in PBS) with antibodies listed above, washed and subsequently incubated with fluorophore-conjugated secondary antibodies (Thermofisher). Cells on the coverslip were mounted on glass slides using ProLong Diamond Antifade Mountant with DAPI stain (Thermofisher). This procedure is described in more detail in \[[@bib61]\]. Image acquisition was performed by a Zeiss 780 inverted confocal laser scanning microscope (CLSM) utilizing a Plan-Apochromat 63 × /1.4 Oil DIC M27 objective. For quantification of IF images a polygonal region of interest (ROI) was drawn manually and used to quantify the pixel mean of the signal in channels of interest. For quantification of nuclear to cytoplasmic (Nucl/Cyto) ratio the nucleus was identified in the DAPI channel and used to draw a ROI. Subsequently, the value of this ROI was measured in the channel of interest and tabulated. The ROI was then moved to the cytoplasm, measured and tabulated. Nucleoli were excluded from ROIs. For quantification of CAV1 or CAVIN1 levels, the confocal plane was selected to be at the base of the cells. ROI of the signal in these images was measured, and tabulated in Microsoft Excel, depending on the absence or presence of YAP/TAZ, TEAD or CAV1 signal, again by flicking between channels in Fiji (ImageJ). Cells undergoing mitosis or with multi nuclei, as determined by DAPI stain, were not included in the quantification. Five to 15 cells of each population, as determined by the presence or absence of signal in the other channel, were quantified from between 8 - 15 different images. The ratios were calculated in Microsoft Excel and plotted as a scatterplot in GraphPad Prism.

### Verteporfin treatment {#sec4.4.7}

HEK293A WT cells were treated with 6.45 μM verteporfin (Sigma-Aldrich) with 1.87% (v/v) dimethyl sulfoxide (DMSO, Sigma-Aldrich) and compared to DMSO treated cells. After 18 hr, mRNA was extracted and RT-qPCR was performed \[[@bib22]\].

### Proximal promoter cloning and luciferase assay {#sec4.4.8}

The upstream promoter regions of *CAV1* and *CAVIN1* were examined for M-CAT and putative TEAD binding motifs. pGL3-basic vectors carrying upstream proximal promoter regions of either *CAV1* (−1907 to +200bp) or *CAVIN1* (−1250 to +150bp) were generated by restriction cloning and insertion into the multiple cloning site using Mlu1/Xho1 (*CAV1*) or Kpn1/Mlu1 (*CAVIN1*) respectively. A short version (−550 to +200bp) of the *CAV1* promoter was also generated, which does not harbor any predicted TEAD recognition sites. HEK293A YAP/TAZ KO cells were co-transfected with either one of the plasmids above and pCMV Flag-YAP. 36-48 hr after transfection cells were lysed using lysis buffer (91.5 mM K~2~HPO~4~, 8.5 mM KH~2~PO~4~, 0.2% Triton X-100 (v/v), 1 mM DTT, 1 mM PMFS) and lysates were transferred into a white 96-well plate (Corning). Luminescence was induced by using the Dual-Glo luciferase assay system (Promega) and was detected by a Biotek HT plate reader. Luciferase activity was normalized to renilla signal.

### Flow studies {#sec4.4.9}

Cells were cultured under laminar flow using the Kirkstall Quasi Vivo QV500 system with a Parker (PF22X0103) peristaltic pump. Cells were seeded onto Thermanox 13 mm coverslips (\#174950, ThermoFisher), or (for IF) poly-D-lysine coated glass coverslips and grown to confluency in complete DMEM containing 10% FBS. The coverslips were transferred into the QV500 system and cells were cultured in DMEM (with supplements as described above) containing 0.1% FBS and a constant flux of 4.7 and 2.1^∗^10^−5^ Dyn/cm^2^, respectively. After 18 hr cells were harvested and analyzed by RT-qPCR, western blotting or IF.

### Zebrafish Yap localization reporter {#sec4.4.10}

Yap localization was assessed specifically in zebrafish epidermal cells by expression of tol2 -*4.4kb*krt18:eGFP-YapS54A. Plasmid DNA was co-injected with Tol2 transposase as well as tol2 h2ax:H2A-mCherry plasmid DNA to mark cell nuclei. The YapS54A mutant (derived from *Danio rerio*) disrupts Tead factor binding and thus prevents deleterious gain-of-function phenotypes \[[@bib34]\]. At 48 hpf, embryos were fixed in 4% paraformaldehyde for 1 hr and then washed extensively in PBST. Embryos were then mounted in 1% agarose and imaged using a 40x water-immersion objective on a Nikon C1 scanning laser confocal microscope. Epidermal cells expressing both eGFP-YapS54A and H2A-mCherry were imaged. For quantifying pixel intensity, image slices with the maximum nuclear diameter were selected. Total fluorescence intensity was calculated for the entire cell and for just the nucleus by measuring the eGFP pixel intensity from the corresponding mCherry fluorescence. Cytoplasmic intensity was calculated by subtracting the nuclear from total cell measurements. Image acquisition and measurements were obtained in a genotype masked manner. Data presented are from 50 cells from at least 10 embryos for each genotype.

For whole mount immunohistochemistry fixed zebrafish embryos were washed in PBST and stored in 100% methanol at −20°C overnight. This was followed by rehydration in solution of incrementally increased PBST concentration (25%, 50%, 75% PBST in methanol) and a final wash in PBST. Subsequently, embryos were incubated in blocking buffer (10% goat serum (Sigma), 0.2% BSA (Sigma) in PBST) for several hours at room temperature. For labeling of YAP, embryos were left in blocking solution with anti-YAP antibody (\#13584-1-AP, Proteintech) at 4°C overnight. After rigorous washing in PBST, embryos were incubated in blocking solution containing secondary antibody (Alexa Fluor 633, A21071, Thermofisher), which was followed by another excessive washing procedure. Nuclei were labeled by Hoechst 3342 (Thermofisher). Finally, embryos were dehydrated in glycerol solutions (30%, 50%, 80% glycerol/PBS) and stored in antifadent (AF1, Citifluor). Labeled zebrafish embryos were mounted in antifadent onto glass slides and microscopic images were taken using the Leica SP8 CLSM utilizing a HC PL APO 40x oil CS2 objective. A single plane image was taken for image analysis. The nuclear to cytoplasmic ratio was quantified in epidermal cells where Hoechst signal (nuclear diameter) was the widest. The nuclear to cytoplasmic YAP ratio in individual cells from at least five separate images from each genotype was plotted in Prism (GraphPad).

### Transmission Electron Microscopy (EM) {#sec4.4.11}

Zebrafish embryos were collected at the 12 somite stage. Briefly, the blocks were trimmed on a Leica RM2255 microtome, and ultra-thin sections were cut and collected on coated grids, and stained with uranyl acetate and lead citrate \[[@bib62]\]. For each embryo, twenty non-overlapping images of epidermis were captured on a Hitachi H600 at 30,000x. Caveolae within the epidermis were quantified for each micrograph in a masked manner where the individual scoring was unaware of the sample genotype. Four embryos were analyzed for each genotype.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Data is represented with significance values (p) used by "^∗^" p \< 0.05, "^∗∗^" p \< 0.01 and "^∗∗∗^" p \< 0.001. All data originated from at least three independent biological replicates if not directly stated otherwise. Data was analyzed using Fiji (ImageJ), Excel (Microsoft) and Prism (GraphPad) software. All statistical analysis and graphs were generated using Prism software. No optimal sample-size estimation was calculated. The genotype of samples imaged in [Figures 4](#fig4){ref-type="fig"}L and 4M were blinded for the person quantifying the number of caveolae. For IF based quantification random images of areas of the coverslips were captured. Cells that had multiple nuclei, were not optimal processed or were undergoing mitosis were not included. All IF based scatterplots were tested and analyzed by unpaired Student's t test, whereas all other data was analyzed using Mann-Whitney, if not stated otherwise. Data are represented as mean ± standard error of the mean (SEM) or standard deviation (SD) as highlighted in figure legends. For correlation analysis, gene expression data across a panel of 967 cancer cell lines were downloaded from the Cancer Cell Line Encyclopedia (CCLE) \[[@bib30]\] and the correlations between mRNA expressions of each pair of genes were evaluated by Pearson's correlation coefficient (r) with two tailed p values, \< 0.05 considered significant.
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